Where does Accumedical Beijing Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Accumedical Beijing Ltd. ranks #34,056 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Accumedical Beijing Ltd. hold?

Accumedical Beijing Ltd. holds 7 US utility patents granted between 2020 and 2024, spanning 9 technology areas.

What is Accumedical Beijing Ltd.'s Innovation Score?

Accumedical Beijing Ltd. has an Innovation Score of 44.7 out of 100 (top 25% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Accumedical Beijing Ltd. focus on?

Accumedical Beijing Ltd.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 3 patents. Grants appear in 9 CPC subclasses total.

Is Accumedical Beijing Ltd.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Accumedical Beijing Ltd..

What does claim depth mean for Accumedical Beijing Ltd.'s patents?

Accumedical Beijing Ltd.'s patents average 17.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Accumedical Beijing Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Accumedical Beijing Ltd.

USPTO PatentsView assignee record - 7 granted patents across 9 technology areas, recorded in grant years 2020–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Accumedical ranks #34,056 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 9 technology areas.

#34,056
of 49,997 US assignees by volume: Top 25%
by Innovation Score (44.7/100): 17.0
avg claims per patent

USPTO PatentsView assignee plate

Corpus R34056 · Foreign Corporation #34,056 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 7 grants
MID-PACK #34,056/49,997
PHOTO-FINISH Abon Pharmaceuticals
CPC-NARROW A61B · 9 areas
INNOV-PAR 44.7/100
CLAIMS-RICH 17.0 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2020–2024 · 5y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Abon Pharmaceuticals, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Accumedical Beijing · this assignee

45
Georg Fischer… · near

45
Jentek Sensors · near

45
Kanagawa University · near

45
Warwick Mills · near

45
3D Lighting… · lowest

7

What this shows Accumedical's Innovation Score is 44.7/100 (top 25% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Accumedical's grants concentrate

Accumedical Beijing Ltd. is a focused PatentsView assignee: 9 CPC subclasses with 42.9% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2023 (4 grants) versus a trough of 1 in 2020. By volume, Accumedical sits between Abon Pharmaceuticals, LLC and Acro Inc..

Accumedical's three-year grant acceleration

Accumedical Beijing Ltd. shows 5 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Abon Pharmaceutic…

7
Acal Energy

7
Accelovant

7
Accor Technology

7
Accurpress America

7
ACG Pam Pharma PVT

7
Achaogen

7
Acro

7
Accumedical Beiji… ◀

7

What this shows Accumedical holds 7 patents at rank #34,052, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Accumedical

By rank, the assignees closest to #34,052 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Accumedical's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Accumedical, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (45 here).

Kanagawa University 45 Warwick Mills, Inc. 45 Jentek Sensors, Inc. 45 Georg Fischer Rohrleitungssysteme AG 45

Accumedical's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

45 Top 25% higher than 75% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Accumedical Beijing Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	1	14.3%
2021	1	14.3%
2023	4	57.1%
2024	1	14.3%

Which technologies does Accumedical Beijing Ltd. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 3

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 3

C08L - Compositions OF Macromolecular Compounds 1

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 1

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 1

D10B - Indexing Scheme Associated With Sublasses OF Section D, Relating TO Textiles 1

D04C - Braiding OR Manufacture OF Lace, Including Bobbin-net OR Carbonised LACE; Braiding MACHINES; BRAID; Lace 1

B29L - Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles 1

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 1

Top 9 of 9 technology areas

Where it ranks

Overall rank by patents

#34,056

of 49,997 tracked assignees

Innovation Score

44.7 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Accumedical Beijing Ltd.'s patent record in context - here's where to go next.

Accumedical Beijing Ltd.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 42.9% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #34,056 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Accumedical Beijing Ltd. against Abon Pharmaceuticals, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 44.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.